Status:
COMPLETED
Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
The Swedish Research Council
Hoffmann-La Roche
Conditions:
Human Immunodeficiency Virus
Chronic Hepatitis C
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to investigate T-cell mediated immune responses to HIV-1 and HCV and determine how these responses are affected by HCV treatment and correlates to response. Furthermore, t...
Eligibility Criteria
Inclusion
- HIV-1 Hepatitis C coinfected adult patients
- Hepatitis C treatment naive
- Stable HIV-1 infection with or without cART
- \> 300 CD4+ cell count
Exclusion
- Decompensated liver disease
- Ongoing depression
- Ongoing drug abuse
- Other contraindications for interferon or ribavirin treatment
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00909129
Last Update
May 27 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital Solna
Stockholm, Sweden, SE-171 77